Thulium Laser Resection of Bladder Tumors vs. Conventional Transurethral Resection of Bladder Tumors for Intermediate and High Risk Non-Muscle-Invasive Bladder Cancer Followed by Intravesical BCG Immunotherapy

Background: Thulium laser resection of bladder tumors (TmLRBT) is recently considered as a common treatment option for non-muscle-invasive bladder cancers (NMIBC), but whether it is superior to Transurethral resection of bladder tumors (TURBT) are still undetermined.Materials and Methods: We retrosp...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Zheng Liu, Gongwei Long, Yucong Zhang, Guoliang Sun, Wei Ouyang, Shen Wang, Hao Xu, Zhihua Wang, Wei Guan, Xiao Yu, Zhiquan Hu, Zhong Chen, Shaogang Wang, Heng Li
Formato:	article
Lenguaje:	EN
Publicado:	Frontiers Media S.A. 2021
Materias:	thulium laser en bloc resection of bladder tumor non-muscle-invasive bladder cancer bacillus Calmette-Guérin vaccine transurethral resection of bladder tumors Surgery RD1-811
Acceso en línea:	https://doaj.org/article/bab02b686df941cb9b9d4cd4932bedb6
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Sea el primero en dejar un comentario!

Thulium Laser Resection of Bladder Tumors vs. Conventional Transurethral Resection of Bladder Tumors for Intermediate and High Risk Non-Muscle-Invasive Bladder Cancer Followed by Intravesical BCG Immunotherapy

Ejemplares similares